相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
Kristen M. Sanfilippo et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study
Fahrettin Covut et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma
Mariana Bastos-Oreiro et al.
CANCER MEDICINE (2021)
The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
Hikmat Abdel-Razeq et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)
Predicting the risk of venous thromboembolism in newly diagnosed myeloma with immunomodulatory drugs: External validation of the IMPEDE VTE score
Emilie Chalayer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma
Onur Kirkizlar et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia
Fatimah Al-Ani et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models
Gouri Dharmavaram et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials
Charlotte A. Bradbury et al.
BLOOD (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study
Kasper Adelborg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
Abu-Sayeef Mirza et al.
THROMBOSIS JOURNAL (2019)
Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Joanna Rupa-Matysek et al.
MEDICAL ONCOLOGY (2018)
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
Cecilie Utke Rank et al.
BLOOD (2018)
Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
Joanna Rupa-Matysek et al.
CANCER MEDICINE (2018)
Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study
Inger Lise Gade et al.
BLOOD ADVANCES (2018)
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas
Roberto Mario Santi et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
Darko Antic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia
Eduard J. Libourel et al.
BLOOD (2016)
Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma
K. M. Sanfilippo et al.
THROMBOSIS RESEARCH (2016)
Venous Thromboembolism in Patients With Myeloma: Incidence and Risk Factors in a Real-World Population
Maeve P. Crowley et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2014)
Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases
Alex J. Walker et al.
EUROPEAN JOURNAL OF CANCER (2013)
Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population
Lee Chun Park et al.
THROMBOSIS RESEARCH (2012)
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
M. Carrier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Incidence and Risk Factors of Venous Thromboembolic Events in Lymphoma
Xiao Zhou et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study
Lesley Mitchell et al.
BLOOD (2010)
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
Sigurdur Y. Kristinsson et al.
BLOOD (2010)
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2010)
Thrombosis in Multiple Myeloma
Sigurdur Yngvi Kristinsson
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
Grace H. Ku et al.
BLOOD (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients
Vanesa Caruso et al.
BLOOD (2006)
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism
Francesca Elice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the eastern cooperative oncology group
SV Rajkumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Venous thromboembolism in patients with diffuse large B-cell lymphoma
Rami S. Komrokji et al.
LEUKEMIA & LYMPHOMA (2006)
The risk of thrombosis in patients with acute leukemia:: occurrence of thrombosis at diagnosis and during treatment
V De Stefano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease
G Srkalovic et al.
CANCER (2004)
High incidence of thromboembolism in patients with central nervous system lymphoma
N Goldschmidt et al.
CANCER (2003)
分享论文
